Compare ACCL & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACCL | VNRX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | Hong Kong | United States |
| Employees | 22 | N/A |
| Industry | Professional Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2M | 22.5M |
| IPO Year | N/A | 2012 |
| Metric | ACCL | VNRX |
|---|---|---|
| Price | $1.40 | $0.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 16.4K | ★ 3.5M |
| Earning Date | 05-20-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | N/A | $355.66 |
| Revenue Next Year | N/A | $849.08 |
| P/E Ratio | $17.13 | ★ N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $1.23 | $0.14 |
| 52 Week High | $5.00 | $0.94 |
| Indicator | ACCL | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.80 | 31.91 |
| Support Level | $1.30 | N/A |
| Resistance Level | $1.60 | $0.18 |
| Average True Range (ATR) | 0.08 | 0.01 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 23.08 | 10.34 |
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.